News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News Aug 03, 2023 Worg secures financing of 130 million Swiss francs The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent ...
Aktuell Aug 03, 2023 Worg erhält Finanzierung von 130 Millionen Franken Das biopharmazeutische chinesische Unternehmen Worg Pharma mit Europasitz in der Basel Area hat in einer Finanzierungsrunde der Serie C umgerechn...
Analisi Mar 22, 2021 Marketing digitale B2B in China Il panorama digitale in Cina è unico e in rapida evoluzione, molto diverso da quello europeo. Per scoprire come se la cavano le aziende svizzere ...
Analyse Mar 22, 2021 Digitales B2B-Marketing in China Die digitale Landschaft in China ist einzigartig und in rasanter Entwicklung, ganz anders als in Europa. Um herauszufinden, wo Schweizer Unterneh...
Analysis Mar 22, 2021 B2B Digital Marketing in China The digital landscape in China is unique and fast-evolving, way different than in Europe. In order to find out how the Swiss companies in China a...
Spotlight Jun 15, 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Aktuell Sep 01, 2020 Polyphor schliesst exklusiven Lizenzvertrag für China Die in der Basel Area ansässige Firma Polyphor hat mit Fosun Pharma eine Vereinbarung getroffen. Die chinesische Fosun Pharma wird Polyphors Wirk...
News Sep 01, 2020 Polyphor awarded exclusive licensing agreement for China The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in China. Fosun Pharma will lead clinical dev...
Actualités Oct 26, 2022 Le fabricant chinois de vaccins CanSino Biologics s’installe à Genève pour lancer son vaccin Covid inhalé Ce premier vaccin Covid inhalé a été approuvé par les autorités chinoises il y a un mois. Cette technologie a également le potentiel de protéger ...
News May 26, 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
Success stories Jul 18, 2018 Biokema erobert China Schritt für Schritt «China zwingt uns dazu, die Dinge anders anzugehen». Florence Cousté-Bémer ist verantwortlich für das internationale Geschäft von Biokema S.A., e...
Success stories Jul 18, 2018 Biokema conquers China one step at a time "China is forcing us to do things differently." Florence Cousté-Bémer, Head of International Activities at Biokema SA, a veterinary pharmaceutica...
Analyse Mar 22, 2021 Marketing digital B2B en Chine En constante évolution, le paysage du numérique chinois est unique en son genre et radicalement différent de son équivalent européen. Afin de sav...
News Oct 26, 2022 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
Report Aug 27, 2021 スイスの循環型経済 現在の直線型経済モデルは「take-make-waste」の原則に支配されています。その結果、生態系や天然資源への圧力が増しています。直線型経済モデルは、資源不足や資源の浪費を生み、最後には気候変動や生物多様性損失などの環境危機が生じます。人類は地球の限界(プラネタリー・バウンダリー)を超...